Growth Differentiation Factor-15 and N-Terminal Pro-BNP in Acute Heart Failure with Preserved Ejection Fraction
Serum GDF15 could be an additional prognostic information to NT-proBNP in patients with HFpEF. The prognostic abilities of serum GDF15 and NT-proBNP differed according to sex. These markers were the feasible markers for patients with HFpEF, identifying those at a high risk for HF-related events and all-cause deaths.
Authors
- Shigehiko Kato (ORCID: https://orcid.org/0000-0003-3308-6392)
- Junya Sato (ORCID: https://orcid.org/0000-0002-1206-2036)
- Satoshi Nishiyama (ORCID: https://orcid.org/0000-0002-3984-8805)
- Yoichiro Otaki (ORCID: https://orcid.org/0000-0001-7859-1427)
- Shingo Tachibana (ORCID: https://orcid.org/0009-0004-6368-6510)
- Mari Shimizu
- Takanori Arimoto (ORCID: https://orcid.org/0000-0003-2802-0794)
- Harutoshi Tamura (ORCID: https://orcid.org/0000-0003-2400-3532)
- Hiroki Takahashi (ORCID: https://orcid.org/0000-0001-6791-936X)
- Masafumi Watanabe (ORCID: https://orcid.org/0000-0002-8672-7483)
- Yuta Kobayashi (ORCID: https://orcid.org/0000-0002-5902-4352)
- Tetsu Watanabe
Institutions
- Yamagata University (JP)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1002/ehf2.15068
- Citations
- 2
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.34